Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -4.35 | 20.53 |
| PEG Ratio (TTM) | -0.48 | 15.73 |
| P/S Ratio (TTM) | 0.41 | 7.15 |
| P/B Ratio (TTM) | 2.63 | 5.96 |
| P/FCF Ratio (TTM) | 8.51 | 16.98 |
| Price to 5YR AVG Earnings Ratio | -21.58 | 106.17 |
| Price to 5YR AVG FCF Ratio | 3.41 | 37.89 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.97% | 1.18% |
| ROE (TTM) | -54.69% | 8.50% |
| Net Profit Margin (TTM) | -13.73% | 4.99% |
| ROIC 5YR AVG | 28.03% | 11.89% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -219.57% | 912.06% | 484.24% |
| Revenue | 6.78% | 35,441.25% | 21,260.57% |
| Net Income | -107.73% | 417.91% | 183.36% |
| Cash Flow | 4,073.56% | 789.20% | 439.85% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.59 | 2.53 |
| Quick Ratio (TTM) | 1.55 | 2.35 |
| D/E Ratio (TTM) | 0.75 | 0.71 |
| Interest Coverage (TTM) | 0.94 | 6.53 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | N/A | 7.76 |
| LTL to 5YR AVG FCF | 0.80 | 1.99 |
| Shares Outstanding Growth 5YR AVG | -13.11% | 4.83% |